Skip to main content
BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.060
-0.030 (-2.75%)
At close: Apr 28, 2026, 4:00 PM EDT
1.050
-0.010 (-0.94%)
Pre-market: Apr 29, 2026, 6:52 AM EDT

BioXcel Therapeutics Revenue

In the year 2025, BioXcel Therapeutics had annual revenue of $642.00K, down -71.67%. BioXcel Therapeutics had revenue of $256.00K in the quarter ending December 31, 2025, a decrease of -30.05%.

Revenue (ttm)
$642.00K
Revenue Growth
-71.67%
P/S Ratio
44.70
Revenue / Employee
$22,138
Employees
29
Market Cap
28.70M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025642.00K-1.62M-71.67%
Dec 31, 20242.27M886.00K64.20%
Dec 31, 20231.38M1.01M268.00%
Dec 31, 2022375.00K--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
InterCure 72.16M
Rockwell Medical 69.26M
Aytu BioPharma 62.64M
Cumberland Pharmaceuticals 44.52M
Zhengye Biotechnology Holding 21.46M
China Pharma Holdings 4.14M
TherapeuticsMD 3.02M
Talphera 28.00K
Revenue Rankings

BTAI News

More News